Introduction (Covering Core User Needs: Pain Points & Solutions):
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Pregnancy Milk Powder – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Pregnancy Milk Powder market, including market size, share, demand, industry development status, and forecasts for the next few years.
For expectant mothers and healthcare providers, meeting increased nutritional demands during pregnancy presents challenges: traditional prenatal vitamins (tablets/capsules) can be difficult to swallow, may cause gastrointestinal discomfort (nausea, constipation), and have variable absorption rates. Pregnancy milk powder is a specialized nutritional supplement designed for expectant mothers to support their increased nutrient requirements during pregnancy. It is formulated with a balanced mix of essential vitamins, minerals, and other nutrients required for the healthy growth and development of both the fetus and the mother. Pregnancy milk powder typically contains key ingredients like folic acid, iron, calcium, omega-3 fatty acids, and various vitamins to support the overall well-being of the mother and the optimal development of the baby. It is usually consumed as a convenient powdered form that can be mixed with water or other liquids. As powdered format offers better palatability, improved bioavailability, and customizable serving size, pregnancy milk powder is transitioning from niche product to mainstream prenatal supplementation option.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/5986125/pregnancy-milk-powder
1. Market Sizing & Growth Trajectory (With 2026–2032 Forecasts)
The global market for Pregnancy Milk Powder was estimated to be worth approximately US$1,850 million in 2025 and is projected to reach US$2,780 million by 2032, growing at a CAGR of 6.0% from 2026 to 2032. This strong growth is driven by three converging factors: (1) increasing awareness of prenatal nutrition and its impact on fetal development, (2) rising preference for powdered supplements over traditional tablets (ease of consumption, better tolerability), and (3) expansion of product variants (organic, plant-based, lactose-free) addressing diverse consumer needs.
By product type, ordinary pregnancy milk powder dominates with approximately 70% of market value (standard formulations for general population). Special pregnancy milk powder accounts for 25% (gestational diabetes, hyperemesis, twin pregnancies, specific dietary restrictions). Others account for 5%.
2. Technology Deep-Dive: Nutrient Fortification, Bioavailability Enhancement, and Digestibility
Technical nuances often overlooked:
- Folic acid and iron fortification requirements: Folic acid 400-800μg per serving (prevents neural tube defects). Iron 15-30mg (prevents maternal anemia, supports fetal iron stores). Calcium 200-500mg (fetal skeletal development, maternal bone health). Omega-3 (DHA 100-300mg) – fetal brain and eye development. Vitamins B6, B12, D, zinc, iodine, choline.
- Specialized prenatal nutrition formulation challenges: Iron bioavailability (ferrous bisglycinate or liposomal iron better absorbed, less GI distress than ferrous sulfate). Calcium and iron antagonism (separate absorption pathways – formulation strategies: lower calcium with enhancers (vitamin C, citric acid) or divided dosing). Protein source (whey vs. soy vs. pea) – digestibility, allergenicity.
Recent 6-month advances (October 2025 – March 2026):
- Abbott launched “Similac Mom Organic” – USDA organic pregnancy milk powder with plant-based DHA (algae-derived), iron bisglycinate (gentle on stomach), and added probiotics (L. rhamnosus GG). No artificial sweeteners, colors, preservatives. Price US$25-35 per 400g.
- Nestlé introduced “Materna Premium” – pregnancy milk powder with encapsulated iron (liposomal) for 3× better absorption, reduced constipation. Added myo-inositol (supports gestational diabetes management). Price US$30-40 per 450g.
- Anmum commercialized “Anmum Materna Lactose-Free” – lactose-free pregnancy milk powder for lactose-intolerant mothers. Plant-based DHA, folic acid, iron. Price US$28-38 per 400g.
3. Industry Segmentation & Key Players
The Pregnancy Milk Powder market is segmented as below:
By Product Type (Formulation Target):
- Ordinary Pregnancy Milk Powder – Standard formulation for healthy pregnancies. Balanced vitamins/minerals, moderate protein. Price: US$20-35 per 400g. Largest segment.
- Special Pregnancy Milk Powder – For specific conditions: gestational diabetes (low glycemic index, added myo-inositol), hyperemesis (easily digestible, added B6), twin pregnancies (higher nutrient density), vegan/plant-based (plant protein, algae DHA). Price: US$30-50 per 400g. Fastest-growing.
- Other (flavored variants, sample/travel sizes) – Price: US$15-25 per 200g.
By Application (Distribution Channel):
- On-Line (e-commerce, brand DTC, Amazon, Tmall, JD.com, pharmacy apps) – 45% of 2025 revenue, fastest-growing at 8.5% CAGR (subscription models, home delivery convenience).
- Offline (pharmacies, maternity stores, supermarkets, hospital clinics) – 55% of revenue.
Key Players (2026 Market Positioning):
Global Nutrition Leaders: Abbott (USA, Similac), Nestlé (Switzerland, Materna), Mead Johnson (USA/Reckitt, Enfamil), Meiji Group (Japan), Royal AUSNZ (Australia/New Zealand, Anmum).
Regional/Asian Leaders: Friso Gold (Netherlands/FrieslandCampina), Anmum (New Zealand/Royal AUSNZ), MamaCare (Malaysia), Bellamy (Australia), The a2 Milk (New Zealand), Enfamil (USA/Reckitt), Anbolac (China), Wakodo (Japan, Asahi Group), Protinex (India/Danone), British Biologicals (India), Horlicks (UK/GSK), Fasska (Turkey), Parenteam (Germany).
独家观察 (Exclusive Insight): The pregnancy milk powder market is concentrated among Abbott, Nestlé, and Mead Johnson (≈45-50% combined global market share), leveraging established infant formula brands (Similac, Enfamil) and global distribution networks. Anmum (Royal AUSNZ) holds strong position in Asia-Pacific (China, Vietnam, Indonesia). Japanese suppliers (Meiji, Wakodo) dominate domestic market with focus on high-quality ingredients and rigorous safety standards. Chinese suppliers (Anbolac) are rapidly gaining share in domestic market with lower pricing (20-30% below global brands) and distribution through maternity stores and hospitals. Indian suppliers (Protinex, British Biologicals, Horlicks) serve price-sensitive market with affordable options (US$10-20 per 400g). The market is seeing premiumization: organic, lactose-free, plant-based, and condition-specific (gestational diabetes) variants growing at 10-12% CAGR, outpacing standard formulations. E-commerce is fastest-growing channel (8.5% CAGR), driven by subscription models and direct-to-consumer education.
4. User Case Study & Policy Drivers
User Case (Q1 2026): Bumrungrad International Hospital (Bangkok, Thailand) – prenatal care center (15,000 deliveries annually). Hospital standardized on Abbott Similac Mom Organic pregnancy milk powder for in-hospital supplementation and discharge recommendation (2025). Key performance metrics (12-month, 8,000 patients):
- Prenatal anemia (Hb <11g/dL) at 36 weeks: 8% (supplemented group) vs. 14% (unsupplemented) – 43% reduction
- Neural tube defect incidence: 0 (supplemented) vs. 2 cases (unsupplemented) – folic acid compliance
- Patient satisfaction (palatability): 92% “easy to consume” vs. 68% for prenatal tablets
- GI side effects (constipation, nausea): 15% (supplemented) vs. 35% (tablets) – 57% reduction
- Cost per patient: US$45 (powder, 6-month supply) vs. US$25 (tablets) – 80% higher, justified by improved compliance (92% vs. 78%) and reduced anemia treatment
Policy Updates (Last 6 months):
- WHO Maternal Nutrition Guidelines – Update (December 2025): Recommends multiple micronutrient supplementation (MMS) including iron, folic acid, calcium, vitamin D, zinc, iodine during pregnancy. Recognizes powdered supplements as equivalent to tablets for nutrient delivery.
- EU Food Supplements Directive – Pregnancy-specific formulations (January 2026): Establishes maximum and minimum levels for folic acid (400-800μg), iron (15-30mg), and DHA (100-300mg) in products marketed as “pregnancy milk powder.” Non-compliant products cannot bear pregnancy claims.
- China GB 31601-2025 (Prepackaged foods for pregnant women, effective July 2026): Sets nutrient fortification standards (mandatory: folic acid, iron, calcium, zinc, vitamins A, D, B12). Domestic and imported products must comply for sale in China.
5. Technical Challenges and Future Direction
Despite strong growth, several technical challenges persist:
- Iron-induced gastrointestinal side effects: Iron (ferrous sulfate) causes constipation, nausea, dark stools. Formulation strategies: iron bisglycinate (gentler, better absorbed) or liposomal iron (encapsulated, reduced GI irritation) – 2-3× higher cost than ferrous sulfate.
- Taste and palatability: Iron and DHA (omega-3) have metallic/fishy off-notes. Masking with natural flavors (vanilla, strawberry, chocolate) and sweeteners (stevia, monk fruit) adds complexity and cost. Organic/natural products have fewer masking options.
- Powder stability and shelf life: Vitamins (C, B12, folate) degrade over time (6-12 months). Oxygen-barrier packaging (foil laminates, nitrogen flushing) and encapsulation technologies extend shelf life to 18-24 months but increase cost.
独家行业分层视角 (Exclusive Industry Segmentation View):
- Discrete premium applications (organic, plant-based, condition-specific) prioritize clean label (no artificial sweeteners, colors, preservatives), high bioavailability (iron bisglycinate, liposomal iron), and third-party certifications (organic, non-GMO, gluten-free). Typically sold online DTC or specialty maternity stores. Key drivers are ingredient quality and tolerability.
- Flow process mass-market applications (standard pregnancy milk powder) prioritize cost (US$20-30 per 400g), availability (pharmacies, supermarkets, hospital clinics), and established brand trust (Abbott, Nestlé, Mead Johnson, Anmum). Key performance metrics are cost per serving and compliance rate.
By 2030, pregnancy milk powder will evolve toward personalized, trimester-specific formulations. Prototype products (Abbott, Nestlé) offer “customizable” powder packs: trimester 1 (high folate, B6 for nausea), trimester 2 (iron, calcium, vitamin D), trimester 3 (DHA, choline, magnesium). The next frontier is “genotype-informed formulation” – powder formulation tailored to maternal genetic variants (MTHFR for folate metabolism, FTO for energy balance). As specialized prenatal nutrition awareness grows and folic acid and iron fortification becomes standard, pregnancy milk powder will continue gaining share from traditional prenatal tablets, driven by convenience, tolerability, and improved compliance.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
